1037816-85-5

Basic information

• Product Name: 5-(4-phenylphenyl)-1H-pyrazole-3-carboxylic acid
• Synonyms: 5-(4-phenylphenyl)-1H-pyrazole-3-carboxylic acid
• CAS NO: 1037816-85-5
• Molecular Formula: C16H12N2O2
• Molecular Weight: 264.27868
• Mol File: 1037816-85-5.mol
• Article Data: 1

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 5-(4-phenylphenyl)-1H-pyrazole-3-carboxylic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 5-(4-phenylphenyl)-1H-pyrazole-3-carboxylic acid(1037816-85-5)
• EPA Substance Registry System: 5-(4-phenylphenyl)-1H-pyrazole-3-carboxylic acid(1037816-85-5)

Safety Data

• Hazardous Substances Data: 1037816-85-5(Hazardous Substances Data)

Usage

General Description

5-(4-phenylphenyl)-1H-pyrazole-3-carboxylic acid is a chemical compound with a molecular formula C17H12N2O2. It is a pyrazole derivative with a carboxylic acid functional group. 5-(4-phenylphenyl)-1H-pyrazole-3-carboxylic acid has potential applications in the pharmaceutical industry, particularly in the development of new drugs for various medical conditions. Its structure contains a phenyl group attached to the pyrazole ring, which can contribute to its pharmacological properties. The carboxylic acid moiety also provides potential for modification and functionalization, allowing for the development of derivatives with improved or specific biological activities. As a result, this compound is of interest for further research and development in the pharmaceutical and biomedical fields.

Upstream product

• 92-52-4 biphenyl 
• 85763-16-2 4-((1,1'-biphenyl)-4-yl)-2,4-dioxobutanoic acid 
• 41350-17-8 ethyl 3-(4-phenylbenzoyl)-2-ketopropionate 
• 92-91-1 biphenyl-4-acetaldehyde 
• 132726-35-3 5-biphenyl-4-yl-1⁽²⁾H-pyrazole-3-carboxylic acid ethyl ester 

Relevant articles and documents

5-Aryl-1H-pyrazole-3-carboxylic acids as selective inhibitors of human carbonic anhydrases IX and XII

Inhibitory activity of a congeneric set of 23 phenyl-substituted 5-phenyl-pyrazole-3-carboxylic acids toward human carbonic anhydrase (hCA, EC 4.2.1.1) isoforms I, II, IX and XII was evaluated by a stopped-flow CO2 hydrase assay. These compounds exerted a clear, selective inhibition of hCA IX and XII over hCAI and II, with Ki in two to one digit micromolar concentrations (4-50 μM). Derivatives bearing bulkier substituents in para-position of the phenyl ring inhibited hCA XII at one-digit micromolar concentrations, while derivatives having alkyl substituents in both ortho- and meta-positions inhibited hCA IX with Kis ranging between 5 and 25 μM. Results of docking experiments offered a rational explanation on the selectivity of these compounds toward CA IX and XII, as well as on the substitution patterns leading to best CA IX or CA XII inhibitors. By examining the active sites of these four isoforms with GRID generated molecular-interaction fields, striking differences between hCA XII and the other three isoforms were observed. The field of hydrophobic probe (DRY) appeared significantly different in CA XII active site, comparing to other three isoforms studied. To the best of our knowledge such an observation was not reported in literature so far. Considering the selectivity of these carboxylates towards membrane-associated over cytosolic CA isoforms, the title compounds could be useful for the development of isoform-specific non-sulfonamide CA inhibitors.